Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. Insights
    3. Alerts
    4. Antitrust implications of COVID-19: FTC Commissioner proposes stopping the “shot clock” on merger reviewsAlerts

    Alert / Antitrust Alert

    Antitrust implications of COVID-19: FTC Commissioner proposes stopping the “shot clock” on merger reviews

    March 20, 2020

    Share

    By Brian Whittaker and Gordon Lang

    FTC Commissioner Chopra suggests pausing the waiting period for government review of reportable mergers and acquisitions during national emergencies, such as the COVID-19 pandemic. 

    DOWNLOADS

    On March 18, 2020, Rohit Chopra, one of five Commissioners of the U.S. Federal Trade Commission (FTC), suggested that the U.S. Congress should enact new legislation or amend current laws, such as the Hart-Scott-Rodino Act (“HSR Act”), to pause the statutory waiting period for government review of mergers and acquisitions during national emergencies, such as the COVID-19 pandemic.

    Under the HSR Act, parties to certain mergers and acquisitions must provide the FTC and U.S. Department of Justice (DOJ) with notice and information about their proposed transactions. Thereafter, the parties to a proposed transaction must wait, generally, for an initial period of 30 days, to allow government review before closing. The purpose of the statutory waiting period is to give the government time to assess whether, in its view, the proposed transaction poses any anticompetitive issues.

    As disruptions caused by the COVID-19 pandemic continue, Commissioner Chopra recently tweeted, “During a national emergency, corporations shouldn’t be able to dictate how government is using limited resources. Under the current law, companies must give notice before closing a big merger. If government doesn’t act within a certain number of days, the merger goes through.” Commissioner Chopra elaborated in a second tweet by stating, “Corporations shouldn’t be able to slip big mergers through during national emergencies. Congress should stop the shot clock so public servants have enough time to investigate and sue to block bad deals.”[1]

    A reactionary change such as that suggested by Chopra would likely result in even more disruptions to businesses who are already grappling with stalled deals during this national emergency. Although the FTC stated earlier this week that review of HSR filings “will continue as normal,”[2] it acknowledged that it “will not be granting” early termination of the HSR waiting period, and it is “reallocating resources” to try to maintain “continuity of core operations” as the COVID-19 pandemic continues.[3]

    Due to rapidly changing responses by the government to the COVID-19 pandemic, businesses that are parties to HSR-reportable mergers and acquisitions should consult with their antitrust counsel to remain up-to-date on the new developments and identify appropriate strategies to comply with the HSR Act.


    1. Available at https://twitter.com/chopraftc/status/1240417656941023234 (last visited Mar. 19, 2020).
      [Back to reference]
    2. U.S. Federal Trade Commission, “COVID-19 — Guidance for Filing Parties” (updated Mar. 17, 2020).
      [Back to reference]
    3. Ian Connor, Bureau of Competition, “Changes in Bureau procedure during COVID-19 coronavirus pandemic” (Mar. 16, 2020).
      [Back to reference]

    Locations

    Washington, DC

    Practices

    M&A and Corporate TransactionsPrivate Equity & Investment FundsSecurities & Capital MarketsGovernment Investigations & White Collar DefenseCongressional InvestigationsAntitrustSecurities & Governance LitigationExport Controls & Economic Sanctions

    Insights And Happenings

    • Alert

      New House committee on coronavirus may shift investigatory landscape for federal fund recipients

      May 1, 2020
    • Alert

      Tracking the global coronavirus (COVID-19) response and its impact on international franchising

      April 10, 2020
    • Alert

      DOJ completes its first expedited antitrust review of collaborative efforts by businesses to respond to COVID-19

      April 9, 2020

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL